TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...

Power Medicine, a company revolutionizing oncology drug development, and AdventHealth, a faith-based health system focused on whole-person care, today announced a strategic collaboration to make ...

The sales agreement contains both financial and data-sharing provisions. PharmAla will seek to ship its LaNeo MDMA Clinical Research Materials to Østfold Hospital Trust at the earliest opportunity, ...

HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing ...

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...

Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026New cleanroom facility allows ...

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...

The clinical-stage biopharmaceutical company announced that its Phase 1 trial showed significant responses in ...

Funding cuts to the National Institutes of Health sent fear through the biotech community in 2025. But new data shows the actual amount of federal funds Massachusetts lost were as bad as was ...